Clinical Trial Update: Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetic interaction between sofosbuvir/velpatasvir/GS-9857 and a hormonal contraceptive (norgestimate/ethinyl estradiol) in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Norgestimate/Ethinyl estradiol oral contraceptive (ethinyl estradiol; norgestimate)
• Sofosbuvir/velpatasvir/GS-9857 fixed-dose combination (sofosbuvir/velpatasvir/GS-9857)

Snippet

Sponsor: Gilead Sciences | Conditions: HCV Infection | Phase 1 | Status: COMPLETED | Results posted: 2020-09-02